NEW YORK, Aug. 25 (GenomeWeb News) - Southern Research Institute, a Birmingham, Ala.-based contract research center, said today that it plans to add proteomics to its pharmaceutical research repertoire.
The institute said it plans to add scientific staff and equipment to support proteomics-related research, and also intends to collaborate with outside parties on proteomics research projects.
"We expect the demand for proteomics to increase as drug companies look to enhance the therapeutic value of their drugs to the patient," said Gregory Gorman, director of the Bioanalytical Sciences department at Southern Research.